Get informed when a big investor buys or sells
+ FollowOvervalued by 68.5% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $15.88 Billion |
|---|---|
| Enterprise Value | $15.56 Billion |
| Annual dividend | $0.46 |
| Dividend yield | 1.14% |
| Earnings per Share | $0.81 |
| Beta | 0.89 |
| Outstanding Shares | 586,936,828 |
| P/E Ratio | 60.6 |
|---|---|
| PEG | -190.74 |
| Price to Sales | 3.86 |
| Price to Book Ratio | 9.0 |
| Enterprise Value to Revenue | 3.4 |
| Enterprise Value to EBIT | 11.19 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.07 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Fisher & Paykel Healthcare Corporation Limited, operating with its various subsidiaries, is a global innovator in medical device technology. The company specializes in the design, production, and worldwide distribution of sophisticated p...